Clinical characteristics and risk factors of cardiac involvement in pediatric immunoglobulin A vasculitis: A 7-year retrospective study from a single tertiary medical center
- PMID: 38300364
- DOI: 10.1007/s00431-024-05438-1
Clinical characteristics and risk factors of cardiac involvement in pediatric immunoglobulin A vasculitis: A 7-year retrospective study from a single tertiary medical center
Abstract
Immunoglobulin A vasculitis(IgAV) is the most common form of systemic vasculitis affecting children. To date, cardiac involvement in pediatric IgAV has not been fully investigated and its prevalence may be underestimated. This study aims to reveal the clinical and laboratory characteristics of cardiac involvement in pediatric IgAV and further determine its risk factors. A total of 1451 children with IgAV were recruited between January 2016 and December 2022. According to the severity of cardiac involvement, the patients were divided into the myocarditis/suspected myocarditis group, cardiac abnormalities group, and non-cardiac involvement group. Demographic, clinical, and laboratory characteristics were retrospectively extracted from the individual data collected in the medical records. Among the 1451 pediatric IgAV patients, 179 (12.3%) were identified with cardiac involvement, including 154 (10.6%) with cardiac abnormalities and 25 (1.7%) with myocarditis/suspected myocarditis. Cardiac involvement in pediatric IgAV mainly manifested as elevated cardiac biomarker levels (n = 162), electrocardiogram abnormalities (n = 46), and echocardiogram/chest X-ray abnormalities (n = 15); however, cardiac-related symptoms were only observed in 15.1% of patients with cardiac involvement. Multivariate analysis demonstrated that interval from disease onset to diagnosis > 7 days (OR, 2.157; 95% CI, 1.523-3.057; p < 0.001), IgAV with multi-organ involvement (OR, 1.806; 95% CI, 1.242-2.627; p = 0.002), and elevated D-dimer levels (OR, 1.939; 95% CI, 1.259-2.985; p < 0.001) were independent risk factors for cardiac involvement in pediatric IgAV. The length of hospital stay was significantly longer in the myocarditis/suspected myocarditis group compared with the other two groups (p < 0.05). Conclusion: This study suggests that cardiac involvements in pediatric IgAV is non-negligible, and cardiac involvement is associated with interval from disease onset to diagnosis > 7 days, IgAV with multi-organ involvement, and elevated D-dimer levels. Severe cardiac involvement may affect the prognosis of pediatric IgAV. What is Known: • Immunoglobulin A vasculitis (IgAV) is the most common form of systemic vasculitis affecting children and adolescents, which exhibits diverse clinical manifestations. Cases of severe IgAV complicated by cardiac involvement have been anecdotally reported. What is New: • The present study suggests that cardiac involvements in pediatric IgAV is non-negligible, and cardiac involvement is associated with interval from disease onset to diagnosis > 7 days, IgAV with multi-organ involvement, and elevated D-dimer levels. Severe cardiac involvement may affect the prognosis of pediatric IgAV.
Keywords: Cardiac involvement; Children; Henoch-Schönlein purpura; Immunoglobulin A vasculitis; Multivariate analysis.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Clinical characteristics and risk factors for kidney involvement in children with immunoglobulin A vasculitis.Pediatr Int. 2024 Jan-Dec;66(1):e15781. doi: 10.1111/ped.15781. Pediatr Int. 2024. PMID: 38863300
-
The Characteristics of Patients With COVID-19-Associated Pediatric Vasculitis: An International, Multicenter Study.Arthritis Rheumatol. 2023 Apr;75(4):499-506. doi: 10.1002/art.42411. Epub 2023 Jan 23. Arthritis Rheumatol. 2023. PMID: 36457245 Free PMC article.
-
Characteristics of cutaneous manifestations in immunoglobulin a vasculitis and their relationships with system involvement and treatment needs.Eur J Pediatr. 2024 Nov 15;184(1):17. doi: 10.1007/s00431-024-05824-9. Eur J Pediatr. 2024. PMID: 39546045
-
Interventions for preventing and treating kidney disease in IgA vasculitis.Cochrane Database Syst Rev. 2023 Feb 28;2(2):CD005128. doi: 10.1002/14651858.CD005128.pub4. Cochrane Database Syst Rev. 2023. PMID: 36853224 Free PMC article. Review.
-
Penile involvement of immunoglobulin a vasculitis/Henoch-Schönlein purpura.J Pediatr Urol. 2021 Jun;17(3):409.e1-409.e8. doi: 10.1016/j.jpurol.2021.01.012. Epub 2021 Jan 22. J Pediatr Urol. 2021. PMID: 33558175 Review.
References
-
- Mao Y, Yin L, Xia H, Huang H, Z Zhou, T Chen, W Zhou (2016) Incidence and clinical features of paediatric 445 vasculitis in Eastern China: 14-year retrospective study 1999–2013. J Int 446 Med Res 44:710–717. https://doi.org/10.1177/0300060515621446 - DOI
-
- Lei WT, Tsai PL, Chu SH, Kao YH, Lin CY, Fang LC, Shyur SD, Lin YW, Wu SII (2018) Incidence and risk factors for recurrent Henoch-Schönlein purpura in children from a 16-year nationwide database. Pediatr Rheumatol Online J 16:25. https://doi.org/10.1186/s12969-018-0247-8 - DOI - PubMed - PMC
-
- Peru H, Soylemezoglu O, Bakkaloglu SA, Elmas S, Bozkaya D, Elmaci AM, Kara F, Buyan N, Hasanoglu E (2008) Henoch Schonlein purpura in childhood: clinical analysis of 254 cases over a 3-year period. Clin Rheumatol 27:1087–1092. https://doi.org/10.1007/s10067-008-0868-2 - DOI - PubMed
-
- Çakıcı EK, Gür G, Yazılıtaş F, Eroğlu FK, Güngör T, Arda N, Orhan D, Özalp Ateş FS, Bülbül M (2019) A retrospective analysis of children with Henoch-Schonlein purpura and re-evaluation of renal pathologies using Oxford classification. Clin Exp Nephrol 23:939–947. https://doi.org/10.1007/s10157-019-01726-5 - DOI - PubMed
-
- Rhim JW, Lee YT, Kang HM, Suh JS, Lee KY (2019) Changes in clinical features in Henoch-Schönlein purpura during three decades: an observational study at a single hospital in Korea. Clin Rheumatol 38:2811–2818. https://doi.org/10.1007/s10067-019-04628-9 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources